Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced its operating results for the second quarter ended June 30, 2012.

Highlights of continuing operations:

  • consolidated revenues were $457.1 million for the quarter, down 2.9 percent as compared to the same period in 2011;
  • consolidated normalized adjusted EBITDAR was $56.2 million for the quarter representing a normalized adjusted EBITDAR margin of 12.3 percent; and
  • normalized earnings per share was $0.15 for the quarter.

Segment Updates

Revenue from Sun's inpatient services business totaled $405.1 million in the second quarter, down $13.4 million, or 3.2 percent, from the second quarter of 2011. The year-over-year decrease in revenues resulted principally from the reduction in Medicare rates as mandated by the CMS Final Rule and implemented on October 1, 2011. Overall patient volumes remained stable at 87.2 percent occupancy for the quarter, consistent with occupancy in both the year-over-year and sequential quarters. The decrease in revenues further resulted in a decrease in adjusted EBITDAR for inpatient services, partially offset by the company's ongoing cost mitigation activities. Adjusted EBITDAR for the quarter was $66.3 million, down $10.9 million or 14.1 percent from the prior year second quarter, while adjusted EBITDAR margin for the quarter was 16.4 percent, down 200 basis points from the prior year second quarter.

As previously disclosed, the Company classified certain operations within its inpatient services business as discontinued. Financial results from these operations are reflected in discontinued operations in Sun's income statement and excluded from its discussion of ongoing operations. Discontinued operations include eight skilled nursing centers and one assisted living center located in the Oklahoma and Rhode Island markets. Discontinued operations include the losses incurred from operating those discontinued centers. The Company is seeking to sell the discontinued centers to unaffiliated third-party operators.

Included in the inpatient services business segment are $15.9 million of revenues from SolAmor, Sun's hospice division, which experienced year-over-year revenue growth of $1.0 million or 6.5 percent in the quarter. SolAmor's adjusted EBITDAR was $3.8 million in the second quarter and adjusted EBITDAR margin was 24.2 percent.

SunDance, Sun's rehabilitation therapy services business, reported second-quarter revenues of $62.0 million, adjusted EBITDAR of $4.0 million and an adjusted EBITDAR margin of 6.4 percent, up 40 basis points year over year. Ongoing changes to SunDance's therapy-delivery processes in response to the CMS Final Rule continued to mitigate the rule's impact.

CareerStaff, Sun's medical staffing services business, reported revenues of $23.5 million, up 3.6 percent year over year, adjusted EBITDAR of $2.0 million and adjusted EBITDAR margin of 8.6 percent, up 60 basis points year over year. On a sequential quarter basis, CareerStaff experienced 2.7 percent revenue growth while billable hours increased on both a sequential quarter and year-over-year basis for the second quarter in a row.

Cash Flow

At June 30, 2012, Sun had $43.6 million in cash and cash equivalents and $89.2 million of long-term debt. During the second quarter, Sun generated cash flow from operations of $7.0 million and used $7.9 million of cash for capital investments. On a normalized basis, operating cash flow for the quarter was $12.9 million after adding back the $5.9 million of Medicaid funds which were temporarily held back by Massachusetts in June 2012 but which were subsequently received by Sun in July 2012.

Transaction Update; Withdrawal of Guidance

The Company filed its definitive proxy statement concerning the transaction with Genesis HealthCare with the Securities and Exchange Commission on July 24, 2012. The Company has commenced mailing the proxy statement to stockholders of the Company and will hold a special stockholders meeting concerning the transaction on September 5, 2012. As previously announced, the closing is expected to occur in the fall. In connection with the transaction, the Company incurred $1.8 million of transaction costs through the six months ended June 30, 2012, which were primarily comprised of legal fees and financial advisory fees. Due to the pending transaction with Genesis HealthCare, the Company is withdrawing its 2012 financial guidance. As previously announced, the Company will not hold a quarterly conference call to discuss its second-quarter results.

Additional Information and Where to Find It

In connection with the proposed transaction with Genesis HealthCare, the Company has filed a proxy statement and other relevant documents concerning the transaction with the Securities and Exchange Commission ("SEC"). Investors and stockholders of the Company are urged to read the definitive proxy statement and other relevant documents because they will contain important information about the transaction. Copies of these documents may be obtained free of charge by making a request to the Company's Investor Relations Department either in writing to Sun Healthcare Group, Inc., 101 Sun Avenue, N.E., Albuquerque, New Mexico 87109, or by telephone to (505) 468-2341. In addition, documents filed with the SEC by the Company may be obtained free of charge at the SEC's website at www.sec.gov or by clicking on "SEC Filings" on the Company's website at www.sunh.com.

The Company and its directors, executive officers and certain employees may be deemed to be participants in the solicitation of proxies from the Company's stockholders in respect of the transaction. Information concerning the ownership of the Company's securities by the Company's directors and executive officers is included in their SEC filings on Forms 3, 4 and 5, and additional information is also available in the Company's definitive proxy statement in connection with the proposed transaction.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc. (NASDAQ: SUNH) is a healthcare services company, serving principally the senior population, with consolidated annual revenues in excess of $1.9 billion and approximately 28,000 employees in 46 states. Sun's services are provided through its subsidiaries: as of June 30, 2012, SunBridge Healthcare and its subsidiaries' continuing operations include 158 skilled nursing centers, 13 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and seven mental health centers with an aggregate of 21,349 licensed beds in 23 states; SunDance Rehabilitation provides rehabilitation therapy services to affiliated and non-affiliated centers in 36 states; CareerStaff Unlimited provides medical staffing services in 40 states; and SolAmor Hospice provides hospice services in 11 states. For more information, go to www.sunh.com.

Forward-looking Statements

Statements made in this release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "anticipate," "believe," "plan," "estimate," "expect," "hope," "intend," "may" and similar expressions. Forward-looking statements in this release include all statements regarding the expected continuing effect of the Company's cost-mitigation and therapy-delivery plans to mitigate the impact on the Company's business of the CMS Final Rule and the Company's expectations regarding the closing of the transaction with Genesis Healthcare. Factors that could cause actual results to differ are identified in filings made by the Company with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements, including with respect to the CMS Final Rule, and the Company's ability to mitigate the impact of such changes; the impact that healthcare reform legislation will have on the Company's business; the ability to maintain the occupancy rates and payor mix at the Company's healthcare centers; potential liability for losses not covered by, or in excess of, insurance; the effects of government regulations and investigations; the ability of the Company to collect its accounts receivable on a timely basis; the amount of the Company's indebtedness; covenants in debt agreements and leases that may restrict the Company's activities, including the Company's ability to make acquisitions and incur more indebtedness on favorable terms; the impact of the economic downturn on the business; increasing labor costs and the shortage of qualified healthcare personnel; the Company's ability to receive increases in reimbursement rates from government payors to cover increased costs; delays in or failure to satisfy required conditions to the closing of the proposed merger with Genesis Healthcare, including the receipt of required regulatory approvals with respect to the transaction and approval of the acquisition by the Company's stockholders; failure to consummate or delay in consummating the transaction for other reasons; and disruption from the transaction making it more difficult to maintain relationships with customers and employees. More information on factors that could affect the Company's business and financial results are included in Sun's filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun's web site, www.sunh.com. There may be additional risks of which the Company is presently unaware or that it currently deems immaterial.

The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control. Sun cautions investors that any forward-looking statements made by Sun are not guarantees of future performance and are only made as of the date of this release. Sun disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

EBITDA, adjusted EBITDA, adjusted EBITDAR and free cash flow, as used in this press release and in the accompanying tables, which are non-GAAP financial measures, are each reconciled to their respective GAAP-recognized financial measures in the accompanying tables.




                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                        KEY INCOME STATEMENT FIGURES
                                CONSOLIDATED
                   (in thousands, except per share data)

                                                  For the        For the
                                                Three Months   Three Months
                                                   Ended          Ended
                                               June 30, 2012  June 30, 2011
                                               -------------  -------------


Revenue                                        $     457,142  $     470,575

Center rent expense                                   36,522         35,750

Depreciation and amortization                          8,504          7,629

Interest expense, net                                  4,429          4,854

Pre-tax income                                         4,874         19,339

Income tax expense                                     1,901          7,894

Income from continuing operations                      2,973         11,445

Loss from discontinued operations                     (3,953)        (1,499)
                                               -------------  -------------

Net (loss) income                              $        (980) $       9,946
                                               =============  =============


Diluted (loss) income per share                $       (0.04) $        0.38
                                               =============  =============


----------------------------------------------------------------------------

Adjusted EBITDAR                               $      54,329  $      67,739
Margin - Adjusted EBITDAR                               11.9%          14.4%

Adjusted EBITDAR normalized                    $      56,167  $      67,739
Margin - Adjusted EBITDAR normalized                    12.3%          14.4%

----------------------------------------------------------------------------


----------------------------------------------------------------------------

Adjusted EBITDA                                $      17,807  $      31,989
Margin - Adjusted EBITDA                                 3.9%           6.8%

Adjusted EBITDA normalized                     $      19,645  $      31,989
Margin - Adjusted EBITDA normalized                      4.3%           6.8%

----------------------------------------------------------------------------


----------------------------------------------------------------------------

Pre-tax income continuing operations -
 normalized                                    $       6,712  $      19,339

Income tax expense - normalized                $       2,618  $       7,894

Income from continuing operations - normalized $       4,094  $      11,445

Diluted earnings per share from continuing
 operations - normalized                       $        0.15  $        0.44

----------------------------------------------------------------------------

See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."

See normalizing adjustments in the table "Normalizing Adjustments - Quarter
Comparison."



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                        KEY INCOME STATEMENT FIGURES
                                CONSOLIDATED
                   (in thousands, except per share data)

                                                  For the        For the
                                                 Six Months     Six Months
                                                   Ended          Ended
                                               June 30, 2012  June 30, 2011
                                               -------------  -------------


Revenue                                        $     915,635  $     936,883

Center rent expense                                   72,899         71,442

Depreciation and amortization                         16,934         15,077

Interest expense, net                                  8,839          9,853

Pre-tax income                                         7,921         35,575

Income tax expense                                     3,089         14,512

Income from continuing operations                      4,832         21,063

Loss from discontinued operations                     (5,599)        (3,005)
                                               -------------  -------------

Net (loss) income                              $        (767) $      18,058
                                               =============  =============


Diluted (loss) income per share                $       (0.03) $        0.70
                                               =============  =============


----------------------------------------------------------------------------

Adjusted EBITDAR                               $     106,593  $     132,250
Margin - Adjusted EBITDAR                               11.6%          14.1%

Adjusted EBITDAR normalized                    $     108,431  $     132,250
Margin - Adjusted EBITDAR normalized                    11.8%          14.1%

----------------------------------------------------------------------------


----------------------------------------------------------------------------

Adjusted EBITDA                                $      33,694  $      60,808
Margin - Adjusted EBITDA                                 3.7%           6.5%

Adjusted EBITDA normalized                     $      35,532  $      60,808
Margin - Adjusted EBITDA normalized                      3.9%           6.5%

----------------------------------------------------------------------------


----------------------------------------------------------------------------

Pre-tax income continuing operations -
 normalized                                    $       9,759  $      35,575

Income tax expense - normalized                $       3,806  $      14,512

Income from continuing operations - normalized $       5,953  $      21,063

Diluted earnings per share from continuing
 operations - normalized                       $        0.22  $        0.81

----------------------------------------------------------------------------

See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."
See normalizing adjustments in the table "Normalizing Adjustments - Quarter
Comparison."



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                        CONSOLIDATED BALANCE SHEETS
                   (in thousands, except per share data)


                                                  June 30,    December 31,
                                                    2012          2011
                                                -----------  --------------
                                                (unaudited)    (unaudited)
                     ASSETS

Current assets:
  Cash and cash equivalents                     $    43,648  $       57,908
  Restricted cash                                    14,330          15,706
  Accounts receivable, net                          212,831         202,229
  Prepaid expenses and other assets                  27,093          29,075
  Assets held for sale                                4,537               -
  Deferred tax assets                                63,018          63,170
                                                -----------  --------------

    Total current assets                            365,457         368,088

Property and equipment, net                         145,673         148,298
Intangible assets, net                               33,991          35,294
Goodwill                                             34,905          34,496
Restricted cash, non-current                            354             353
Deferred tax assets                                 124,382         123,974
Other assets                                         43,152          45,163
                                                -----------  --------------

    Total assets                                $   747,914  $      755,666
                                                ===========  ==============


      LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable                              $    44,603  $       55,888
  Accrued compensation and benefits                  63,878          61,101
  Accrued self-insurance obligations, current
   portion                                           57,628          57,810
  Other accrued liabilities                          47,638          43,139
  Current portion of long-term debt and capital
   lease obligations                                    967           1,017
                                                -----------  --------------

    Total current liabilities                       214,714         218,955

Accrued self-insurance obligations, net of
 current portion                                    155,048         157,267
Long-term debt and capital lease obligations,
 net of current portion                              88,242          88,768
Unfavorable lease obligations, net                    5,880           7,110
Other long-term liabilities                          56,107          58,110
                                                -----------  --------------

    Total liabilities                               519,991         530,210


Stockholders' equity:
  Preferred stock of $.01 par value, authorized
   3,333 shares, zero shares were issued and
   outstanding as of June 30, 2012 and December
   31, 2011                                               -               -
  Common stock of $.01 par value, authorized
   41,667 shares, 25,535 and 25,146 shares
   issued and outstanding as of June 30, 2012
   and December 31, 2011, respectively                  255             251
  Additional paid-in capital                        730,242         726,861
  Accumulated deficit                              (501,194)       (500,427)
  Accumulated other comprehensive loss, net          (1,380)         (1,229)
                                                -----------  --------------
                                                    227,923         225,456
                                                -----------  --------------
    Total liabilities and stockholders' equity  $   747,914  $      755,666
                                                ===========  ==============



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                       CONSOLIDATED INCOME STATEMENTS
                   (in thousands, except per share data)

                                                  For the        For the
                                                Three Months   Three Months
                                                   Ended          Ended
                                               June 30, 2012  June 30, 2011
                                               -------------  -------------
                                                (unaudited)    (unaudited)

Total net revenues                             $     457,142  $     470,575
                                               -------------  -------------
Costs and expenses:
  Operating salaries and benefits                    259,506        263,461
  Self-insurance for workers' compensation and
   general and professional liability
   insurance                                          13,190         14,541
  Operating administrative costs                      11,703         13,305
  Other operating costs                               95,429         92,159
  Center rent expense                                 36,522         35,750
  General and administrative expenses                 16,048         14,952
  Depreciation and amortization                        8,504          7,629
  Provision for losses on accounts receivable          5,099          4,418
  Interest, net of interest income of $67 and
   $82, respectively                                   4,429          4,854
  Transaction costs                                    1,838              -
  Restructuring costs                                      -            167
                                               -------------  -------------
Total costs and expenses                             452,268        451,236
                                               -------------  -------------

Income before income taxes and discontinued
 operations                                            4,874         19,339
Income tax expense                                     1,901          7,894
                                               -------------  -------------
Income from continuing operations                      2,973         11,445
                                               -------------  -------------

Loss from discontinued operations, net                (3,953)        (1,499)

                                               -------------  -------------
Net (loss) income                              $        (980) $       9,946
                                               =============  =============


Basic loss per common and common equivalent
 share:
  Income from continuing operations            $        0.11  $        0.44
  Loss from discontinued operations, net               (0.15)         (0.06)
                                               -------------  -------------
Net (loss) income                              $       (0.04) $        0.38
                                               =============  =============

Diluted loss per common and common equivalent
 share:
  Income from continuing operations            $        0.11  $        0.44
  Loss from discontinued operations, net               (0.15)         (0.06)
                                               -------------  -------------
Net (loss) income                              $       (0.04) $        0.38
                                               =============  =============

Weighted average number of common and common
 equivalent shares outstanding:
  Basic                                               27,039         26,146
  Diluted                                             27,039         26,187



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                       CONSOLIDATED INCOME STATEMENTS
                   (in thousands, except per share data)

                                                  For the        For the
                                                 Six Months     Six Months
                                                   Ended          Ended
                                               June 30, 2012  June 30, 2011
                                               -------------  -------------
                                                (unaudited)    (unaudited)

Total net revenues                             $     915,635  $     936,883
                                               -------------  -------------
Costs and expenses:
  Operating salaries and benefits                    520,595        525,943
  Self-insurance for workers' compensation and
   general and professional liability
   insurance                                          28,507         29,098
  Operating administrative costs                      24,110         26,372
  Other operating costs                              191,995        183,294
  Center rent expense                                 72,899         71,442
  General and administrative expenses                 32,089         30,331
  Depreciation and amortization                       16,934         15,077
  Provision for losses on accounts receivable          9,908          9,595
  Interest, net of interest income of $135 and
   $140, respectively                                  8,839          9,853
  Transaction costs                                    1,838              -
  Restructuring costs                                      -            303
                                               -------------  -------------
Total costs and expenses                             907,714        901,308
                                               -------------  -------------

Income before income taxes and discontinued
 operations                                            7,921         35,575
Income tax expense                                     3,089         14,512
                                               -------------  -------------
Income from continuing operations                      4,832         21,063
                                               -------------  -------------

Loss from discontinued operations, net                (5,599)        (3,005)

                                               -------------  -------------
Net (loss) income                              $        (767) $      18,058
                                               =============  =============


Basic loss per common and common equivalent
 share:
  Income from continuing operations            $        0.18  $        0.81
  Loss from discontinued operations, net               (0.21)         (0.11)
                                               -------------  -------------
Net (loss) income                              $       (0.03) $        0.70
                                               =============  =============

Diluted loss per common and common equivalent
 share:
  Income from continuing operations            $        0.18  $        0.81
  Loss from discontinued operations, net               (0.21)         (0.11)
                                               -------------  -------------
Net (loss) income                              $       (0.03) $        0.70
                                               =============  =============

Weighted average number of common and common
 equivalent shares outstanding:
  Basic                                               26,542         25,899
  Diluted                                             26,542         25,967



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                   CONSOLIDATED STATEMENTS OF CASH FLOWS
                               (in thousands)

                                                  For the        For the
                                                Three Months   Three Months
                                                   Ended          Ended
                                               June 30, 2012  June 30, 2011
                                               -------------  -------------
                                                (unaudited)    (unaudited)

Cash flows from operating activities:
  Net (loss) income                            $        (980) $       9,946
  Adjustments to reconcile net (loss) income
   to net cash provided by operating
   activities, including discontinued
   operations:
    Depreciation and amortization                      8,504          7,863
    Amortization of favorable and unfavorable
     lease intangibles                                  (507)          (490)
    Provision for losses on accounts
     receivable                                        5,341          4,860
    Loss on sale of assets, including
     discontinued operations, net                         69              -
    Stock-based compensation expense                   1,576          1,352
    Deferred taxes                                       103          7,944
  Changes in operating assets and liabilities,
   net of acquisitions:
    Accounts receivable                              (11,428)        (7,185)
    Restricted cash                                       (6)            18
    Prepaid expenses and other assets                    573            439
    Accounts payable                                  (4,078)        (1,582)
    Accrued compensation and benefits                  7,384         (4,018)
    Accrued self-insurance obligations                    68         (2,569)
    Income taxes payable                                   -           (478)
    Other accrued liabilities                          2,892           (216)
    Other long-term liabilities                       (2,481)          (492)
                                               -------------  -------------
      Net cash provided by operating
       activities                                      7,030         15,392
                                               -------------  -------------

Cash flows from investing activities:
  Capital expenditures                                (7,868)        (9,319)
  Acquisitions, net of cash acquired                       -           (356)
                                               -------------  -------------
    Net cash used for investing activities            (7,868)        (9,675)
                                               -------------  -------------

Cash flows from financing activities:
  Principal repayments of long-term debt and
   capital lease obligations                            (285)        (2,800)
                                               -------------  -------------
    Net cash used for financing activities              (285)        (2,800)
                                               -------------  -------------

Net (decrease) increase in cash and cash
 equivalents                                          (1,123)         2,917
Cash and cash equivalents at beginning of
 period                                               44,771         85,572
                                               -------------  -------------
Cash and cash equivalents at end of period     $      43,648  $      88,489
                                               =============  =============

----------------------------------------------------------------------------
Reconciliation of net cash provided by
 operating activities to free cash flow:

    Net cash provided by operating activities  $       7,030  $      15,392
    Capital expenditures                              (7,868)        (9,319)
                                               -------------  -------------
      Free cash flow                           $        (838) $       6,073
                                               =============  =============

----------------------------------------------------------------------------

Free cash flow is defined as net cash flow provided by operating activities
less cash used for capital expenditures.
Free cash flow is used by management to evaluate discretionary cash flow
potentially available for principal repayment and other financing
activities.



               SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                  CONSOLIDATED STATEMENTS OF CASH FLOWS
                              (in thousands)

                                                  For the       For the
                                                Six Months    Six Months
                                                   Ended         Ended
                                                 June 30,      June 30,
                                                   2012          2011
                                               ------------  ------------
                                                (unaudited)   (unaudited)

Cash flows from operating activities:
  Net (loss) income                            $       (767) $     18,058

  Adjustments to reconcile net (loss) income
   to net cash provided by operating
   activities, including discontinued
   operations:
    Depreciation and amortization                    17,086        15,544
    Amortization of favorable and unfavorable
     lease intangibles                               (1,020)         (974)
    Provision for losses on accounts
     receivable                                      10,463        10,504
    Loss on sale of assets, including
     discontinued operations, net                        69             -
    Stock-based compensation expense                  3,808         2,801
    Deferred taxes                                     (157)        9,976
  Changes in operating assets and liabilities,
   net of acquisitions:
    Accounts receivable                             (21,209)      (12,578)
    Restricted cash                                   1,375        (1,928)
    Prepaid expenses and other assets                 2,325           190
    Accounts payable                                (10,114)       (3,501)
    Accrued compensation and benefits                 2,777          (580)
    Accrued self-insurance obligations               (2,401)       (3,912)
    Other accrued liabilities                         4,423          (946)
    Other long-term liabilities                      (2,254)       (1,218)
                                               ------------  ------------
      Net cash provided by operating
       activities                                     4,404        31,436
                                               ------------  ------------

Cash flows from investing activities:
  Capital expenditures                              (17,829)      (18,156)
  Acquisitions, net of cash acquired                   (260)         (356)
                                               ------------  ------------
    Net cash used for investing activities          (18,089)      (18,512)
                                               ------------  ------------

Cash flows from financing activities:
  Borrowings of long-term debt
  Principal repayments of long-term debt and
   capital lease obligations                           (575)       (5,598)
                                               ------------  ------------
    Net cash used for financing activities             (575)       (5,598)
                                               ------------  ------------

Net decrease in cash and cash equivalents           (14,260)        7,326
Cash and cash equivalents at beginning of
 period                                              57,908        81,163
                                               ------------  ------------
Cash and cash equivalents at end of period     $     43,648  $     88,489
                                               ============  ============

--------------------------------------------------------------------------
Reconciliation of net cash provided by
 operating activities to free cash flow:

    Net cash provided by operating activities  $      4,404  $     31,436
    Capital expenditures                            (17,829)      (18,156)
                                               ------------  ------------
      Free cash flow                           $    (13,425) $     13,280
                                               ============  ============

--------------------------------------------------------------------------

Free cash flow is defined as net cash flow provided by operating activities
less cash used for capital expenditures.
Free cash flow is used by management to evaluate discretionary cash flow
potentially available for principal repayment and other financing
activities.



                 SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

     RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
                               (in thousands)

                                                  For the         For the
                                                Three Months    Three Months
                                                   Ended           Ended
                                               June 30, 2012   June 30, 2011
                                               -------------   -------------
                                                (unaudited)     (unaudited)

Total net revenues                             $     457,142   $     470,575
                                               -------------   -------------

Net (loss) income                              $        (980)  $       9,946
                                               -------------   -------------


  Income from continuing operations                    2,973          11,445

  Income tax expense                                   1,901           7,894

  Interest, net                                        4,429           4,854

  Depreciation and amortization                        8,504           7,629
                                               -------------   -------------

EBITDA                                         $      17,807   $      31,822


  Restructuring costs                                      -             167

                                               -------------   -------------

Adjusted EBITDA                                $      17,807   $      31,989

  Center rent expense                                 36,522          35,750
                                               -------------   -------------


Adjusted EBITDAR                               $     54,329    $      67,739
                                               =============   =============

EBITDA is defined as earnings before loss on discontinued operations, income
taxes, interest, net, depreciation and amortization. Adjusted EBITDA is
defined as EBITDA before restructuring costs. Adjusted EBITDAR is defined as
Adjusted EBITDA before center rent expense. Adjusted EBITDA and Adjusted
EBITDAR are used by management to evaluate financial performance and
resource allocation for each entity within the operating units and for the
Company as a whole. Adjusted EBITDA and Adjusted EBITDAR are commonly used
as analytical indicators within the healthcare industry and also serve as
measures of leverage capacity and debt service ability. Adjusted EBITDA and
Adjusted EBITDAR should not be considered as measures of financial
performance under generally accepted accounting principles. As the items
excluded from Adjusted EBITDA and Adjusted EBITDAR are significant
components in understanding and assessing finance performance, Adjusted
EBITDA and Adjusted EBITDAR should not be considered in isolation or as
alternatives to net income, cash flows generated by or used in operating,
investing or financing activities or other financial statement data
presented in the consolidated financial statements as indicators of
financial performance or liquidity. Because Adjusted EBITDA and Adjusted
EBITDAR are not measurements determined in accordance with U.S. generally
accepted accounting principles and are thus susceptible to varying
calculations. Adjusted EBITDA and Adjusted EBITDAR as presented may not be
comparable to other similarly titled measures of other companies.



                 SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

     RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
                               (in thousands)

                                                For the          For the
                                               Six Months       Six Months
                                                 Ended            Ended
                                             June 30, 2012    June 30, 2011
                                            ---------------  ---------------
                                              (unaudited)      (unaudited)

Total net revenues                          $       915,635  $       936,883
                                            ---------------  ---------------

Net (loss) income                           $          (767) $        18,058
                                            ---------------  ---------------


  Income from continuing operations                   4,832           21,063

  Income tax expense                                  3,089           14,512

  Interest, net                                       8,839            9,853

  Depreciation and amortization                      16,934           15,077
                                            ---------------  ---------------

EBITDA                                      $        33,694  $        60,505

  Restructuring costs                                     -              303

                                            ---------------  ---------------

Adjusted EBITDA                             $        33,694  $        60,808

  Center rent expense                                72,899           71,442
                                            ---------------  ---------------

Adjusted EBITDAR                            $       106,593  $       132,250
                                            ===============  ===============

EBITDA is defined as earnings before loss on discontinued operations, income
taxes, interest, net, depreciation and amortization. Adjusted EBITDA is
defined as EBITDA before restructuring costs. Adjusted EBITDAR is defined as
Adjusted EBITDA before center rent expense. Adjusted EBITDA and Adjusted
EBITDAR are used by management to evaluate financial performance and
resource allocation for each entity within the operating units and for the
Company as a whole. Adjusted EBITDA and Adjusted EBITDAR are commonly used
as analytical indicators within the healthcare industry and also serve as
measures of leverage capacity and debt service ability. Adjusted EBITDA and
Adjusted EBITDAR should not be considered as measures of financial
performance under generally accepted accounting principles. As the items
excluded from Adjusted EBITDA and Adjusted EBITDAR are significant
components in understanding and assessing finance performance, Adjusted
EBITDA and Adjusted EBITDAR should not be considered in isolation or as
alternatives to net income, cash flows generated by or used in operating,
investing or financing activities or other financial statement data
presented in the consolidated financial statements as indicators of
financial performance or liquidity. Adjusted EBITDA and Adjusted EBITDAR are
not measurements determined in accordance with U.S. generally accepted
accounting principles and are thus susceptible to varying calculations.
Adjusted EBITDA and Adjusted EBITDAR as presented may not be comparable to
other similarly titled measures of other companies.



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

   RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED
                         EBITDA and ADJUSTED EBITDAR
                              ($ in thousands)

                  For the Three Months Ended June 30, 2012
                                (unaudited)

                         Rehabili-                     Elimination
                          tation    Medical                of
              Inpatient  Therapy   Staffing  Other &   Affiliated  Consolid-
               Services  Services  Services  Corp Seg    Revenue     ated
               --------  --------  --------  --------  ----------  --------

Nonaffiliated
 revenue       $405,135  $ 29,197  $ 22,804  $      6  $        -  $457,142
Affiliated
 revenue              -    32,804       719         -     (33,523)        -
               --------  --------  --------  --------  ----------  --------
  Total
   revenue     $405,135  $ 62,001  $ 23,523  $      6  $  (33,523) $457,142
               --------  --------  --------  --------  ----------  --------

Income (loss)
 from
 continuing
 operations    $ 22,975  $  3,551  $  1,676  $(25,229) $        -  $  2,973

Income tax
 expense              -         -         -     1,901           -     1,901

Interest, net        (8)        -        (3)    4,440           -     4,429

Depreciation
 and
 amortization     7,115       260       187       942           -     8,504
               --------  --------  --------  --------  ----------  --------

  EBITDA       $ 30,082  $  3,811  $  1,860  $(17,946) $        -  $ 17,807

Restructuring
 costs                -         -         -         -           -         -
               --------  --------  --------  --------  ----------  --------

  Adjusted
   EBITDA      $ 30,082  $  3,811  $  1,860  $(17,946) $        -  $ 17,807

Center rent
 expense         36,207       145       170         -           -    36,522
               --------  --------  --------  --------  ----------  --------

  Adjusted
   EBITDAR     $ 66,289  $  3,956  $  2,030  $(17,946) $        -  $ 54,329
               ========  ========  ========  ========  ==========  ========


  Normalized
   Adjusted
   EBITDA      $ 30,082  $  3,811  $  1,860  $(16,108) $        -  $ 19,645
  Normalized
   Adjusted
   EBITDAR     $ 66,289  $  3,956  $  2,030  $(16,108) $        -  $ 56,167


     Adjusted
       EBITDA
       margin       7.4%      6.1%      7.9%                            3.9%

     Adjusted
      EBITDAR
       margin      16.4%      6.4%      8.6%                           11.9%

   Normalized
     Adjusted
       EBITDA
       margin       7.4%      6.1%      7.9%                            4.3%

   Normalized
     Adjusted
      EBITDAR
       margin      16.4%      6.4%      8.6%                           12.3%

See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."
See normalizing adjustments in the table "Normalizing Adjustments - Quarter
Comparison."



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

   RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED
                         EBITDA and ADJUSTED EBITDAR
                              ($ in thousands)

                   For the Six Months Ended June 30, 2012
                                (unaudited)

                           Rehabili-                    Elimination
                            tation   Medical               of
                 Inpatient Therapy  Staffing Other &   Affiliated  Consolid-
                  Services Services Services Corp Seg    Revenue     ated
                  -------- -------- -------- --------  ----------  --------

Nonaffiliated
 revenue          $810,923 $ 59,826 $ 44,873 $     13  $        -  $915,635
Affiliated
 revenue                 -   66,267    1,550        -     (67,817)        -
                  -------- -------- -------- --------  ----------  --------
  Total revenue   $810,923 $126,093 $ 46,423 $     13  $  (67,817) $915,635
                  -------- -------- -------- --------  ----------  --------

Income (loss)
 from continuing
 operations       $ 42,323 $  7,313 $  3,108 $(47,912) $        -  $  4,832

Income tax
 expense                 -        -        -    3,089           -     3,089

Interest, net          (28)       -       (3)   8,870           -     8,839

Depreciation and
 amortization       14,144      511      371    1,908           -    16,934
                  -------- -------- -------- --------  ----------  --------

  EBITDA          $ 56,439 $  7,824 $  3,476 $(34,045) $        -  $ 33,694


Restructuring
 costs                   -        -        -        -           -         -
                  -------- -------- -------- --------  ----------  --------


  Adjusted EBITDA $ 56,439 $  7,824 $  3,476 $(34,045) $        -  $ 33,694

Center rent
 expense            72,282      279      338        -           -    72,899
                  -------- -------- -------- --------  ----------  --------

  Adjusted
   EBITDAR        $128,721 $  8,103 $  3,814 $(34,045) $        -  $106,593
                  ======== ======== ======== ========  ==========  ========


  Normalized
   Adjusted
   EBITDA         $ 56,439 $  7,824 $  3,476 $(32,207) $        -  $ 35,532
  Normalized
   Adjusted
   EBITDAR        $128,721 $  8,103 $  3,814 $(32,207) $        -  $108,431


  Adjusted EBITDA
           margin      7.0%     6.2%     7.5%                           3.7%

 Adjusted EBITDAR
           margin     15.9%     6.4%     8.2%                          11.6%

       Normalized
  Adjusted EBITDA
           margin      7.0%     6.2%     7.5%                           3.9%

       Normalized
 Adjusted EBITDAR
           margin     15.9%     6.4%     8.2%                          11.8%

See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."
See normalizing adjustments in the table "Normalizing Adjustments - Year to
Date Comparison."



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

   RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED
                         EBITDA and ADJUSTED EBITDAR
                              ($ in thousands)

                  For the Three Months Ended June 30, 2011
                                (unaudited)

                           Rehabili-                    Elimination
                            tation   Medical               of
                 Inpatient Therapy  Staffing Other &   Affiliated  Consolid-
                  Services Services Services Corp Seg    Revenue     ated
                  -------- -------- -------- --------  ----------  --------

Nonaffiliated
 revenue          $418,584 $ 29,979 $ 21,998 $     14  $        -  $470,575
Affiliated
 revenue                 -   33,225      699        -     (33,924)        -
                  -------- -------- -------- --------  ----------  --------
  Total revenue   $418,584 $ 63,204 $ 22,697 $     14  $  (33,924) $470,575
                  -------- -------- -------- --------  ----------  --------

Income (loss)
 from continuing
 operations       $ 35,202 $  3,427 $  1,462 $(28,646) $        -  $ 11,445

Income tax
 expense                 -        -        -    7,894           -     7,894

Interest, net          (31)       -        -    4,885           -     4,854

Depreciation and
 amortization        6,354      227      187      861           -     7,629
                  -------- -------- -------- --------  ----------  --------

  EBITDA          $ 41,525 $  3,654 $  1,649 $(15,006) $        -  $ 31,822

Restructuring
 costs                 167        -        -        -           -       167
                  -------- -------- -------- --------  ----------  --------

  Adjusted EBITDA $ 41,692 $  3,654 $  1,649 $(15,006) $        -  $ 31,989

Center rent
 expense            35,453      127      170        -           -    35,750
                  -------- -------- -------- --------  ----------  --------

  Adjusted
   EBITDAR        $ 77,145 $  3,781 $  1,819 $(15,006) $        -  $ 67,739
                  ======== ======== ======== ========  ==========  ========




  Adjusted EBITDA
           margin     10.0%     5.8%     7.3%                           6.8%

 Adjusted EBITDAR
           margin     18.4%     6.0%     8.0%                          14.4%

See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

   RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED
                         EBITDA and ADJUSTED EBITDAR
                              ($ in thousands)

                   For the Six Months Ended June 30, 2011
                                (unaudited)

                           Rehabili-                    Elimination
                            tation   Medical               of
                 Inpatient Therapy  Staffing Other &   Affiliated  Consolid-
                  Services Services Services Corp Seg    Revenue     ated
                  -------- -------- -------- --------  ----------  --------

Nonaffiliated
 revenue          $832,471 $ 60,077 $ 44,314 $     21  $        -  $936,883
Affiliated
 revenue                 -   65,920    1,321        -     (67,241)        -
                  -------- -------- -------- --------  ----------  --------
  Total revenue   $832,471 $125,997 $ 45,635 $     21  $  (67,241) $936,883
                  -------- -------- -------- --------  ----------  --------

Income (loss)
 from continuing
 operations       $ 68,541 $  6,199 $  2,861 $(56,538) $        -  $ 21,063

Income tax
 expense                 -        -        -   14,512           -    14,512

Interest, net          (37)       -        1    9,889           -     9,853

Depreciation and
 amortization       12,560      453      374    1,690           -    15,077
                  -------- -------- -------- --------  ----------  --------

  EBITDA          $ 81,064 $  6,652 $  3,236 $(30,447) $        -  $ 60,505

Restructuring
 costs                 303        -        -        -           -       303
                  -------- -------- -------- --------  ----------  --------

  Adjusted EBITDA $ 81,367 $  6,652 $  3,236 $(30,447) $        -  $ 60,808

Center rent
 expense            70,845      254      343        -           -    71,442
                  -------- -------- -------- --------  ----------  --------

  Adjusted
   EBITDAR        $152,212 $  6,906 $  3,579 $(30,447) $        -  $132,250
                  ======== ======== ======== ========  ==========  ========




  Adjusted EBITDA
           margin      9.8%     5.3%     7.1%                           6.5%

 Adjusted EBITDAR
           margin     18.3%     5.5%     7.8%                          14.1%

See definitions of EBITDA, Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."



                Sun Healthcare Group, Inc. and Subsidiaries
                       Selected Operating Statistics
                           Continuing Operations

                           For the                       For the
                      Three Months Ended            Six Months Ended
                           June 30,                     June 30,
                   -----------------------       ----------------------
                     2012           2011           2012          2011
Consolidated
 Company
----------------------------------------------------------------------------

Revenues - Non-
 affiliated (in
 thousands)
  Skilled Nursing
   and similar
   facilities      $388,810       $403,221       $779,244      $802,775
  Hospice            15,869         14,907         30,771        28,762
  Other -
   Inpatient
   Services             456            456            908           934
                   --------       --------       --------      --------
    Inpatient
     Services       405,135        418,584        810,923       832,471

  Rehabilitation
   Therapy
   Services          29,197         29,979         59,826        60,077
  Medical Staffing
   Services          22,804         21,998         44,873        44,314
  Other - non-core
   businesses             6             14             13            21
                   --------       --------       --------      --------
    Total          $457,142       $470,575       $915,635      $936,883
                   ========       ========       ========      ========


Revenue Mix - Non-
 affiliated (in
 thousands)
  Medicare         $133,399   29% $154,193   33% $269,688  29% $305,443  33%
  Medicaid          188,851   41%  179,578   38%  375,293  41%  357,223  38%
  Private and
   Other            106,376   24%  108,343   23%  213,636  24%  217,629  23%
  Managed Care /
   Insurance         23,405    5%   23,347    5%   46,743   5%   46,356   5%
  Veterans            5,111    1%    5,114    1%   10,275   1%   10,232   1%
                   --------  ---  --------  ---  -------- ---  -------- ---
    Total          $457,142  100% $470,575  100% $915,635 100% $936,883 100%
                   ========  ===  ========  ===  ======== ===  ======== ===


----------------------------------------------------------------------------

Inpatient Services
 Stats
----------------------------------------------------------------------------

  Number of
   centers:             190            190            190           190
  Number of
   available beds:   20,756         20,820         20,756        20,820
  Occupancy %:         87.2%          87.2%          87.2%         87.4%


  Payor Mix %
   based on
   patient days:
      Medicare -
       SNF Beds        14.8%          15.9%          15.0%         15.9%
      Managed care
       / Ins. -
       SNF Beds         4.1%           4.0%           4.0%          4.1%
                   --------       --------       --------      --------
        Total SNF
         skilled
         mix           18.9%          19.9%          19.0%         20.0%
                   --------       --------       --------      --------

  Medicare             13.5%          14.6%          13.7%         14.5%
  Medicaid             63.7%          62.0%          63.5%         62.1%
  Private and
   Other               17.7%          18.4%          17.8%         18.4%
  Managed Care /
   Insurance            3.8%           3.7%           3.7%          3.7%
  Veterans              1.3%           1.3%           1.3%          1.3%

Revenue Mix % of
 revenues:
    Medicare - SNF
     Beds              30.8%          35.2%          31.2%         35.1%
    Managed care /
     Ins. - SNF
     Beds               6.1%           5.9%           6.1%          5.9%
                   --------       --------       --------      --------
      Total SNF
       skilled mix     36.9%          41.1%          37.3%         41.0%
                   --------       --------       --------      --------

  Medicare             31.8%          35.8%          32.1%         35.6%
  Medicaid             46.6%          42.9%          46.3%         42.9%
  Private and
   Other               14.6%          14.6%          14.6%         14.8%
  Managed Care /
   Insurance            5.7%           5.5%           5.7%          5.5%
  Veterans              1.3%           1.2%           1.3%          1.2%


Revenues PPD:
  Medicare (Part
   A)              $ 461.80       $ 520.51       $ 462.46      $ 521.31
  Medicare Blended
   Rate (Part A &
   B)              $ 508.06       $ 557.95       $ 507.02      $ 558.11
  Medicaid         $ 180.08       $ 175.49       $ 179.36      $ 174.59
  Medicaid, net of
   provider taxes  $ 162.91       $ 160.19       $ 162.26      $ 159.41
  Private and
   Other           $ 190.00       $ 188.15       $ 190.09      $ 192.13
  Managed Care /
   Insurance       $ 371.57       $ 380.42       $ 376.47      $ 374.50
  Veterans         $ 245.54       $ 246.89       $ 248.31      $ 246.20

----------------------------------------------------------------------------

Rehab contracts
----------------------------------------------------------------------------

  Affiliated            178            179            178           179
  Non-affiliated        332            342            332           342

  Average Qtrly
   Revenue per
   Contract (in
   thousands)      $    122       $    121       $    124      $    121
----------------------------------------------------------------------------



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

                NORMALIZING ADJUSTMENTS - QUARTER COMPARISON
                   (in thousands, except per share data)


                              AS REPORTED - 2nd QUARTER 2012
              -------------------------------------------------------------
                                                 Income
                                                  from                Net
                       Adjusted Adjusted  Pre-  Continuing  Disc    (Loss)
              Revenue  EBITDAR  EBITDA    tax   Operations   Ops    Income
              -------- -------  -------  ------  --------  -------  -------

As Reported
 2nd QUARTER
 2012         $457,142 $54,329  $17,807  $4,874  $  2,973  $(3,953) $  (980)
   Percent of
      Revenue             11.9%     3.9%    1.1%      0.7%    -0.9%    -0.2%

Normalizing
 Adjustments:

  Transaction
   costs             -   1,838    1,838   1,838     1,121        -    1,121
              -------- -------  -------  ------  --------  -------  -------

Normalized As
 Reported -
 2nd QUARTER
 2012         $457,142 $56,167  $19,645  $6,712  $  4,094  $(3,953) $   141
              ======== =======  =======  ======  ========  =======  =======
   Percent of
      Revenue             12.3%     4.3%    1.5%      0.9%    -0.9%     0.0%

  Diluted
   EPS:
  As Reported                                    $   0.11  $ (0.15) $ (0.04)
As Normalized                                    $   0.15  $ (0.14) $  0.01



                              AS REPORTED - 2nd QUARTER 2011
              -------------------------------------------------------------
                                                    Income
                                                     from
                       Adjusted  Adjusted  Pre-   Continuing  Disc     Net
              Revenue  EBITDAR   EBITDA    tax    Operations  Ops    Income
              -------- --------  --------  ------- -------- -------  ------

As Reported -
 2nd QUARTER
 2011         $470,575 $ 67,739  $ 31,989  $19,339 $ 11,445 $(1,499) $9,946
   Percent of
      Revenue              14.4%      6.8%     4.1%     2.4%   -0.3%    2.1%

Normalizing
 Adjustments:

  None               -        -         -        -        -       -       -
              -------- --------  --------  ------- -------- -------  ------

Normalized As
 Reported -
 2nd QUARTER
 2011         $470,575 $ 67,739  $ 31,989  $19,339 $ 11,445 $(1,499) $9,946
              ======== ========  ========  ======= ======== =======  ======
   Percent of
      Revenue              14.4%      6.8%     4.1%     2.4%   -0.3%    2.1%


    Diluted
     EPS:
  As Reported                                      $   0.44 $ (0.06) $ 0.38
As Normalized                                      $   0.44 $ (0.06) $ 0.38

See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."

Normalizing adjustments are transactions or adjustments not related to
ongoing operations and consist of transaction costs associated with the
Company's sale to Genesis Healthcare.

Since normalizing adjustments are not measurements determined in accordance
with U.S. generally accepted accounting principles and are thus susceptible
to varying calculations and interpretations, the information presented
herein may not be comparable to other similarly described information of
other companies.



                SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

             NORMALIZING ADJUSTMENTS - YEAR TO DATE COMPARISON
                   (in thousands, except per share data)


                               AS REPORTED - SIX MONTHS 2012
               ------------------------------------------------------------
                                                   Income
                                                    from              Net
                        Adjusted  Adjusted  Pre- Continuing  Disc    (Loss)
               Revenue  EBITDAR   EBITDA    tax  Operations  Ops     Income
               -------- --------  -------- ------ -------- -------  -------

As Reported -
 Six Months
 2012          $915,635 $106,593  $ 33,694 $7,921 $  4,832 $(5,599) $  (767)
    Percent of
       Revenue              11.6%      3.7%   0.9%     0.5%   -0.6%    -0.1%

Normalizing
 Adjustments:

  Transaction
   costs              -    1,838     1,838  1,838    1,121       -    1,121
               -------- --------  -------- ------ -------- -------  -------

Normalized As
 Reported -
 Six Months
 2012          $915,635 $108,431  $ 35,532 $9,759 $  5,953 $(5,599) $   354
               ======== ========  ======== ====== ======== =======  =======
    Percent of
       Revenue              11.8%      3.9%   1.1%     0.7%   -0.6%     0.0%

    Diluted
     EPS:
   As Reported                                    $   0.18 $ (0.21) $ (0.03)
 As Normalized                                    $   0.22 $ (0.21) $  0.01



                              AS REPORTED - SIX MONTHS 2011
              -------------------------------------------------------------
                                                   Income
                                                    from
                       Adjusted  Adjusted Pre-   Continuing  Disc    Net
              Revenue  EBITDAR   EBITDA    tax   Operations  Ops     Income
              -------- --------  -------- ------- -------- -------  -------

As Reported -
 Six Months
 2011         $936,883 $132,250  $ 60,808 $35,575 $ 21,063 $(3,005) $18,058
   Percent of
      Revenue              14.1%      6.5%    3.8%     2.2%   -0.3%     1.9%

Normalizing
 Adjustments:

  None               -        -         -       -        -       -        -
              -------- --------  -------- ------- -------- -------  -------

Normalized As
 Reported -
 Six Months
 2011         $936,883 $132,250  $ 60,808 $35,575 $ 21,063 $(3,005) $18,058
              ======== ========  ======== ======= ======== =======  =======
   Percent of
      Revenue              14.1%      6.5%    3.8%     2.2%   -0.3%     1.9%


    Diluted
     EPS:
  As Reported                                     $   0.81 $ (0.11) $  0.70
As Normalized                                     $   0.81 $ (0.11) $  0.70

See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table
"Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDAR."

Normalizing adjustments are transactions or adjustments not related to
ongoing operations and consist of transaction costs associated with the
Company's sale to Genesis Healthcare.

Since normalizing adjustments are not measurements determined in accordance
with U.S. generally accepted accounting principles and are thus susceptible
to varying calculations and interpretations, the information presented
herein may not be comparable to other similarly described information of
other companies.

Contact: Investor Inquiries (505) 468-2341 Media Inquiries (505) 468-4582

Sun Healthcare (NASDAQ:SUNH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Sun Healthcare
Sun Healthcare (NASDAQ:SUNH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Sun Healthcare